Software validation ensures that the controls and processes expected by your business take place correctly. Software validation is the process of verifying and providing proof that the software performs as intended. This validation is crucial to maintain compliance, quality, and safety in areas such as clinical trials, manufacturing, and data management. Standards such as GAMP5 and regulations such as 21 CFR Part 11 and EU Annex 11 play a key role in this.
Quality & reliability through software validation
Ensuring regulatory compliance
Your Benefits
Regulatory compliance
Adhering to industry standards and regulations, such as FDA guidelines, EMA regulations, and GxP requirements, software validation ensures that systems meet compliance requirements and helps to avoid legal penalties.
Enhanced reliability
Computer systems operate correctly and consistently, minimizing disruptions in critical processes such as clinical trials, drug manufacturing and laboratory operations.
Data integrity
Validating processes and data flows safeguards the integrity and accuracy of crucial data, essential for patient safety, product efficacy, and regulatory reporting.
Risk mitigation
Identifying and addressing potential system vulnerabilities reduces the risk of security breaches, data loss, and other threats that could compromise patient safety and product quality.
Cost reduction
Proactive assurance measures help to prevent costly system failures and to reduce the need for extensive corrective actions, thereby optimizing resource allocation and operational efficiency.
Our solutions and concepts for your future
Software validation in Life Sciences – our use cases
Our projects include clients from various backgrounds, as the following use cases demonstrate.
Pharmaceutical industry
Ensuring compliance with FDA regulations for electronic records and signatures, and validating systems used in drug manufacturing and clinical trials. This includes for instance laboratory information management systems (LIMS) or manufacturing execution systems (MES).
Clinical research
Validating clinical trial management systems (CTMS), electronic data capture (EDC) systems and other digital tools used in clinical research to ensure the integrity and reliability of clinical trial data.
Biotechnology
Validating systems used for genetic engineering, bioinformatics and molecular diagnostics to ensure data accuracy and regulatory compliance, supporting innovative therapies and diagnostic tools.
Medical devices
Verifying software embedded in medical devices, as well as systems used for device manufacturing and post-market surveillance, to ensure patient safety and compliance with regulatory standards like ISO 13485.
Healthcare
Ensuring the reliability and security of electronic health record (EHR) systems, patient management systems, and other healthcare IT solutions to enhance patient care and comply with healthcare regulations like HIPAA.
Two ways of software validation
Both Computerized Software Validation (CSV) and Computer System Assurance (CSA) aim to ensure the reliability and compliance of computer systems.
Computerized software validation takes a traditional approach complying with regulatory requirements like FDA's 21 CFR Part 11 and EU Annex 11 for Pharma and MedTech companies. It involves validating the entire lifecycle of a system, from planning and development to operation and retirement, using the V-Model framework. The V-Model illustrates the relationship between each phase of development and its corresponding phase of testing, ensuring thorough validation at every stage. This process requires extensive documentation, including validation plans, protocols, test scripts, traceability matrices, and final reports, to demonstrate compliance and maintain data integrity. Through comprehensive risk management and a focus on functionality and quality, CSV ensures systems produce reliable, accurate, and consistent results, thereby supporting product quality and patient safety.
Computer system assurance is a modern validation approach focusing on critical thinking. The FDA recently introduced CSA as new guideline for MedTech companies, which emphasizes the efficient use of resources and adaptability to rapid technological advancements, such as automated testing, continuous integration and flexible validation practices. CSA includes risk management in a way that high-risk areas are prioritized for guaranteeing product quality and patient safety in the validation process. Organizations in regulated industries can benefit from understanding and appropriately applying both methodologies to meet their specific needs and regulatory requirements.
More about the topic
Do you have questions?
No website and no brochure can replace a personal conversation about your goals and issues. I look forward to hearing from you.
Head of Business Line Life Sciences Lars Schmiedeberg +41 58 520 97 20